| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |